Skip to main content

Table 4 Significant difference ( P= 0.005)ain types of event in DS-ALL and non-DS-ALL patients treated according to the ALL-1992/2000 protocols

From: Clinical and genetic features of pediatric acute lymphoblastic leukemia in Down syndrome in the Nordic countries

Events DS-ALL (% of events) non-DS-ALL (% of events)
Relapse 23 (66) 507 (80)
Induction failure 9b (26) 47 (7.4)
DCR1 3 (8.6) 48 (7.6)
SMN 0 (0) 32 (5.0)
  1. DS-ALL, Down syndrome-related acute lymphoblastic leukemia; DCR1, death in complete remission 1; SMN, second malignant neoplasm.
  2. aMann-Whitney U test.
  3. bSix of the 9 patients with induction failure died due to toxicity.